University of Wisconsin Foundation’s Akero Therapeutics AKRO Stock Holding History

University of Wisconsin Foundation’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-328,504	Closed	-$15.6M	–	9
2025 Q3	$15.6M	Hold	328,504	–	–	13.21%	3
2025 Q2	$17.5M	Hold	328,504	–	–	19.61%	3
2025 Q1	$13.3M	Sell	328,504 -82,126	-20%	-$3.48M	11.28%	5
2024 Q4	$11.4M	Sell	410,630 -13,219	-3%	-$400K	8.3%	6
2024 Q3	$12.2M	Hold	423,849	–	–	7.93%	5
2024 Q2	$9.94M	Buy	423,849 +51,274	+14%	+$1.1M	11.19%	5
2024 Q1	$9.41M	Hold	372,575	–	–	10.62%	5
2023 Q4	$8.7M	Buy	372,575 +268,759	+259%	+$5.3M	14.48%	4
2023 Q3	$5.25M	Buy	+103,816	New	+$4.83M	6.02%	4

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

University of Wisconsin Foundation's AKRO Position: Q4 2025 in Review

University of Wisconsin Foundation sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 328,504 shares — an estimated $15.6M sold.

University of Wisconsin Foundation first reported a position in AKRO in Q3 2023 and held it in 9 quarters. The position peaked at $17.5M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

University of Wisconsin Foundation reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
University of Wisconsin Foundation sold 328,504 Akero Therapeutics shares in Q4 2025, an estimated $15.6M.
University of Wisconsin Foundation first reported a position in Akero Therapeutics in Q3 2023 and held it in 9 quarters.
University of Wisconsin Foundation's Akero Therapeutics position peaked at $17.5M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on University of Wisconsin Foundation's 13F filing for Q4 2025, filed 13 Feb 2026.